Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Giselle Saurez"'
Autor:
Giselle Saurez-Martínez, Carmen Elena Viada-González, Mabel Álvarez-Cardona, Patricia Piedra-Sierra, Dayamí Trujillo-Fornaris, Linet Gorrita-Mora, Laudelina Rodríguez-Lastre, Belkis Felicia Gómez-Escobar, Rinaldo Puga-Gómez, Belinda Sánchez-Ramírez
Publikováno v:
VacciMonitor, Vol 32 (2023)
Las vacunas SOBERANA®02 y SOBERANA® Plus contra el coronavirus tipo 2 causante del síndrome respiratorio agudo severo, recibieron autorización de uso en emergencia por la autoridad reguladora de Cuba, y de inmediato aconteció una campaña de vac
Externí odkaz:
https://doaj.org/article/f135a7bcbbda4aa0bddd1cd665c7d85a
Autor:
Laura Elena Alvaré, Alena Salvato Dueñas, Danusia Felipe Mallea, Mairaly Porta Diaz, Berta Lidia Acevedo Castro, Joel Manuel Quintana Guerra, Karen Urrutia Pérez, Klaudia Urrutia Pérez, Yenima Martin Bauta, Marel Alonso Valdés, Lissete Barroso Márquez, Verena Lucila Muzio González, Carmen Elena Viada González, Giselle Saurez Martínez, Francisco Hernández Bernal
Publikováno v:
Revista Cubana de Medicina Militar, Vol 52, Iss 3, Pp e02302991-e02302991 (2023)
Introduction: The clinical evaluation of anti-COVID-19 vaccines in pediatric population, is a challenge in times of pandemic, to respond to the urgency of representative samples that contribute to the reproducibility of the study in the real populati
Externí odkaz:
https://doaj.org/article/e826b7620c854008a5cb50e12e3d2951
Publikováno v:
Biotecnología Aplicada, Vol 31, Iss 2, Pp 159-167
Nimotuzumab, a humanized monoclonal antibody, is a novel drug against the epidermal growth factor receptor, which is a protein that is highly expressed in malignant tumors of epithelial origin. This paper presents its physicochemical and pharmaceutic
Externí odkaz:
https://doaj.org/article/776d22177f864799a421ceb733848114
Autor:
Martínez, Giselle Saurez1 giselle@cim.sld.cu, Salva Camaño, Silvia Noema2, Sierra, Patricia Piedra3, Castillo, Bárbara Iglesias4, Jiménez, Carolina Toledo5, Solomón Cardona, María Teresa6, Álvarez, Eduardo Santiesteban7, Méndez, Javier Figueredo8, Santos, Ana de la Torre9, Quintanal Cordero, Nelson Ernesto10, Selva Infante, Julio César11, Fernández, Sandra González12, Piña, Rolando Uranga13, Dávila, Agustín Lage14
Publikováno v:
Revista Cubana de Neurología y Neurocirugía. 2015, Vol. 5 Issue 2, p123-132. 10p.
Autor:
Ricardo Cabanas Armada, Luis Valle Garrido, Daniel Darias Zayas, Agustín Lage Dávila, Luis Quevedo Sotolongo, Gretel Rodriguez Cruz, Giselle Saurez Martínez, Evelio González Dalmau, Carlos Cabal Mirabal, Mercedes Monzón Fernández, Martha Ríos Castillo, José Carlos Ugarte Suárez
Publikováno v:
Pediatrics International. 56:43-46
Background Nimotuzumab, a humanized monoclonal antibody anti-epidermal growth factor receptor, has been shown to improve survival and quality of life in patients with pediatric malignant brain tumor. It is necessary, however, to increase the objectiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2c5a3ea28369218bf8215d7a9092294d
https://doi.org/10.1111/ped.12212
https://doi.org/10.1111/ped.12212
Autor:
Diaz-Miqueli, Arlhee1 arlhee@cim.sld.cu, Martinez, Giselle Saurez2
Publikováno v:
OncoTargets & Therapy. 2013, Vol. 6, p931-942. 12p.
Autor:
Jorge Luis Pedrayes, Giselle Saurez, Ricardo Cabanas, Adnolys Reyes, Myrna Moreno, Jose Valdes, Mariela Infante, María Caridad González, Jose Alert, Patricia Lorenzo Luaces, Ernesto Echevarria, Raiza Herrera, Tania Crombet Ramos, Martha Rios, Melba Avila
Publikováno v:
mAbs. 5:202-207
Brain tumors are a major cause of cancer-related mortality in children. Overexpression of epidermal growth factor receptor (EGFR) is detected in pediatric brain tumors and receptor density appears to increase with tumor grading. Nimotuzumab is an IgG
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b3115a627d40dd75c0b3bddc5e77526
https://doi.org/10.4161/mabs.22970
https://doi.org/10.4161/mabs.22970
Publikováno v:
Bionatura. 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4c54c1423243bca11c5dcb7f880d8bcb
https://doi.org/10.21931/rb/2016.01.04.3
https://doi.org/10.21931/rb/2016.01.04.3
Autor:
Yisel Avila, Meylan Cepeda, Adriana Carr, Carmen Viada, Ana de la Torre, Giselle Saurez, Elias Gracia, Kirenia Perez, Luis E. Fernández, Edmundo Reigosa, Migdalia Rodríguez, Julio Hernandez, Marta Osorio
Publikováno v:
Cancer Management and Research
Marta Osorio,1 Elias Gracia,1 Edmundo Reigosa,1 Julio Hernandez,2 Ana de la Torre,2 Giselle Saurez,3 Kirenia Perez,3 Carmen Viada,3 Meylán Cepeda,2 Adriana Carr,3 Yisel Ávila,4 Migdalia Rodríguez,4 Luis E Fernandez31National Institute of Oncology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6e5d413d5c572f783b6b0322edb6fa7
http://europepmc.org/articles/PMC3468021
http://europepmc.org/articles/PMC3468021
Autor:
T. Combet, Giselle Saurez, Rolando Pérez, R.M. Diaz, A.G. De la Torre, Rolando Rives, Alain Diaz, Ana María Vázquez, Elia Neninger, A.M. Alfonso, Mariano R. Gabri, Daniel F. Alonso, Bárbara Wilkinson
Publikováno v:
Scopus-Elsevier
1E10 is an anti-idiotype murine monoclonal antibody (Ab2 MAb) specific to an Ab1 MAb which reacts with NeuGc-containing gangliosides, sulfatides and with antigens expressed in some human tumors. Preparations containing this Ab2 were capable to induce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c7149cedb5f9ebb7a15ba46868ac479
https://doi.org/10.4161/cbt.6.2.3574
https://doi.org/10.4161/cbt.6.2.3574